Wird geladen...
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy
CDK4 & 6 inhibitors have enhanced the effectiveness of endocrine therapy (ET) in patients with advanced breast cancer (ABC). This paper presents exploratory analyses examining patient and disease characteristics that may inform in whom and when abemaciclib should be initiated. MONARCH 2 and 3 en...
Gespeichert in:
| Veröffentlicht in: | NPJ Breast Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299082/ https://ncbi.nlm.nih.gov/pubmed/30588487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-018-0094-2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|